Prometheus Biosciences Inc (RXDX) PT Raised to $65 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Jeff Jones raised the price target on Prometheus Biosciences Inc (NASDAQ: RXDX) to $65.00 (from $50.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
